Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Valneva raises EUR 40.2 million

Valneva SE (Euronext:VLA; VSE:VLA) raised EUR 40.2 million ($52.3 million) through

Read the full 116 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE